• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心性浆液性脉络膜视网膜病变及眼部合并症

Central Serous Chorioretinopathy and Ocular Comorbidities.

作者信息

Samanta Anindya, Driban Matthew, Sahoo Niroj, Parameswarappa Deepika, Singh Sumit Randhir, Caplash Sonny, Mishra Pranjal, Agrawal Rohit, Venkatesh Ramesh, Maltsev Dmitrii S, Chhablani Jay

机构信息

Department of Ophthalmology, Baylor College of Medicine, Houston, TX 77030, USA.

UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

J Clin Med. 2025 Jan 23;14(3):720. doi: 10.3390/jcm14030720.

DOI:10.3390/jcm14030720
PMID:39941390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11818775/
Abstract

/: Central serous chorioretinopathy (CSCR) is a common retinopathy that can present with other concurrent diseases; thus, further research into the prevalence of other ocular comorbidities in eyes with CSCR is required. : This retrospective, multicentric, cross-sectional observational study reviewed the charts of 9157 patients. Of them, 579 (6.32%) patients and 766 eyes had an additional ocular comorbidity, in addition to CSCR, in at least one subject eye. : The baseline best-corrected visual acuity (BCVA) of the subjects eyes was 0.49 ± 0.36 logMAR. The average BCVA of subject eyes with coexisting macular diseases was 0.50 logMAR, while the corresponding BCVA of subject eyes with coexisting peripheral disease was 0.55 logMAR. The most prevalent coexisting macular diseases were non-proliferative diabetic retinopathy (26.8%), non-exudative age-related macular degeneration (AMD) (7.6%) and hypertensive retinopathy (3.0%). The most prevalent coexisting non-macular diseases were lattice degeneration (8.9%), optic atrophy (5.1%), rhegmatogenous retinal detachment (1.70%) and optic disc pit (1.7%). The odds of having a comorbid disease in the same eye as CSCR were statistically significant for branch retinal vein occlusion (OR 11.56, -value = 0.02) and non-exudative AMD (OR 2.06; -value = 0.01); additionally, there was a trend towards significance for idiopathic polypoidal choroidal vasculopathy (OR 4.43; -value = 0.05) when compared to the eyes without CSCR. : Certain diseases are more likely to coexist in eyes with CSCR. Additionally, eyes with CSCR may have statistically significant odds of certain diseases when compared to eyes without CSCR.

摘要

中心性浆液性脉络膜视网膜病变(CSCR)是一种常见的视网膜病变,可伴有其他并发疾病;因此,需要进一步研究CSCR患者中其他眼部合并症的患病率。:这项回顾性、多中心、横断面观察性研究回顾了9157例患者的病历。其中,579例(6.32%)患者和766只眼除了患有CSCR外,至少一只患眼中还存在其他眼部合并症。:患眼的基线最佳矫正视力(BCVA)为0.49±0.36 logMAR。合并黄斑疾病的患眼平均BCVA为0.50 logMAR,而合并周边疾病的患眼相应BCVA为0.55 logMAR。最常见的合并黄斑疾病是非增殖性糖尿病视网膜病变(26.8%)、非渗出性年龄相关性黄斑变性(AMD)(7.6%)和高血压视网膜病变(3.0%)。最常见的合并非黄斑疾病是格子样变性(8.9%)、视神经萎缩(5.1%)、孔源性视网膜脱离(1.70%)和视盘小凹(1.7%)。与无CSCR的眼相比,与CSCR同侧眼患合并症的几率在视网膜分支静脉阻塞(OR 11.56,P值=0.02)和非渗出性AMD(OR 2.06;P值=0.01)方面具有统计学意义;此外,与无CSCR的眼相比,特发性息肉状脉络膜血管病变(OR 4.43;P值=0.05)有显著趋势。:某些疾病更易与CSCR共存于同一眼中。此外,与无CSCR的眼相比,患有CSCR的眼患某些疾病的几率可能具有统计学意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2348/11818775/733da9f3de14/jcm-14-00720-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2348/11818775/dfa855f8179c/jcm-14-00720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2348/11818775/6b622307062c/jcm-14-00720-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2348/11818775/733da9f3de14/jcm-14-00720-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2348/11818775/dfa855f8179c/jcm-14-00720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2348/11818775/6b622307062c/jcm-14-00720-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2348/11818775/733da9f3de14/jcm-14-00720-g003.jpg

相似文献

1
Central Serous Chorioretinopathy and Ocular Comorbidities.中心性浆液性脉络膜视网膜病变及眼部合并症
J Clin Med. 2025 Jan 23;14(3):720. doi: 10.3390/jcm14030720.
2
Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.在并存的糖尿病性视网膜病变中鉴定中心性浆液性脉络膜视网膜病变的生物标志物:一项多模态成像研究。
Br J Ophthalmol. 2020 Jul;104(7):904-909. doi: 10.1136/bjophthalmol-2019-314077. Epub 2019 Sep 28.
3
Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变病程中的神经节细胞丢失
Ophthalmol Ther. 2023 Feb;12(1):517-533. doi: 10.1007/s40123-022-00625-5. Epub 2022 Dec 12.
4
Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy.视力与基于多模态成像的中心性浆液性脉络膜视网膜病变分类相关。
Eye (Lond). 2022 Mar;36(3):517-523. doi: 10.1038/s41433-021-01788-4. Epub 2021 Oct 13.
5
A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的多中心长期疗效研究
Am J Ophthalmol. 2016 Oct;170:91-99. doi: 10.1016/j.ajo.2016.07.026. Epub 2016 Aug 9.
6
Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy.与中心性浆液性脉络膜视网膜病变相关的囊样黄斑变性的光相干断层扫描血管造影表现。
Br J Ophthalmol. 2019 Nov;103(11):1615-1618. doi: 10.1136/bjophthalmol-2018-313048. Epub 2019 Jan 2.
7
One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis.中心性浆液性脉络膜视网膜病变的一年结局及治疗结局预测因素:基于多模态成像的分析
Eur J Ophthalmol. 2022 Jul;32(4):2319-2327. doi: 10.1177/11206721211055018. Epub 2021 Nov 6.
8
Evaluation of the Retinal Vessel Density and Subfoveal Choroidal Thickness in Central Cerous Chorioretinopathy Using Optical Coherence Tomography.使用光学相干断层扫描技术评估中心性浆液性脉络膜视网膜病变的视网膜血管密度和黄斑中心凹下脉络膜厚度
Cureus. 2023 May 8;15(5):e38691. doi: 10.7759/cureus.38691. eCollection 2023 May.
9
Genetic associations of central serous chorioretinopathy subtypes, neovascular age-related macular degeneration, and polypoidal choroidal vasculopathy.中心性浆液性脉络膜视网膜病变亚型、新生血管性年龄相关性黄斑变性和息肉样脉络膜血管病变的遗传关联。
Asia Pac J Ophthalmol (Phila). 2024 Jan-Feb;13(1):100003. doi: 10.1016/j.apjo.2023.100003. Epub 2023 Nov 25.
10
Flavoprotein fluorescence elevation is a marker of mitochondrial oxidative stress in patients with retinal disease.黄素蛋白荧光升高是视网膜疾病患者线粒体氧化应激的一个标志物。
Front Ophthalmol (Lausanne). 2023 Feb 16;3:1110501. doi: 10.3389/fopht.2023.1110501. eCollection 2023.

本文引用的文献

1
Pachychoroid Spectrum Disease: Underlying Pathology, Classification, and Phenotypes.脉络膜增厚谱疾病:潜在病理学、分类和表型。
Curr Eye Res. 2021 Oct;46(10):1437-1448. doi: 10.1080/02713683.2021.1942073. Epub 2021 Aug 2.
2
Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern®.玻璃体后脱离、视网膜裂孔和格子样变性首选实践模式®
Ophthalmology. 2020 Jan;127(1):P146-P181. doi: 10.1016/j.ophtha.2019.09.027. Epub 2019 Sep 25.
3
Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
在并存的糖尿病性视网膜病变中鉴定中心性浆液性脉络膜视网膜病变的生物标志物:一项多模态成像研究。
Br J Ophthalmol. 2020 Jul;104(7):904-909. doi: 10.1136/bjophthalmol-2019-314077. Epub 2019 Sep 28.
4
Combined Parafoveal Telangiectasia, Multifocal Central Serous Chorioretinopathy, and Choroidal Hemangioma.合并性黄斑旁毛细血管扩张症、多灶性中心性浆液性脉络膜视网膜病变和脉络膜血管瘤。
Middle East Afr J Ophthalmol. 2019 Jan-Mar;26(1):49-51. doi: 10.4103/meajo.MEAJO_92_18.
5
Risk factors for incident central serous retinopathy: case-control analysis of a US national managed care population.中心性浆液性脉络膜视网膜病变发病风险因素:美国全国管理式医疗人群病例对照分析。
Br J Ophthalmol. 2019 Dec;103(12):1784-1788. doi: 10.1136/bjophthalmol-2018-313050. Epub 2019 Mar 14.
6
Clinical profile of uveitis patients developing central serous chorioretinopathy: An experience at a tertiary eye care center in India.印度一家三级眼科护理中心的经验:葡萄膜炎患者发生中心性浆液性脉络膜视网膜病变的临床特征。
Indian J Ophthalmol. 2019 Feb;67(2):247-251. doi: 10.4103/ijo.IJO_831_18.
7
Masqueraders of central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的伪装者。
Surv Ophthalmol. 2019 Jan-Feb;64(1):30-44. doi: 10.1016/j.survophthal.2018.09.001. Epub 2018 Sep 20.
8
CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.2型特发性黄斑毛细血管扩张症与中心性浆液性脉络膜视网膜病变并存
Retina. 2018 Jan;38 Suppl 1(Suppl 1):S67-S78. doi: 10.1097/IAE.0000000000001836.
9
POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY: Pachychoroid Spectrum of Diseases.息肉样脉络膜血管病变合并中心性浆液性脉络膜视网膜病变:厚脉络膜疾病谱。
Retina. 2018 Jun;38(6):1195-1204. doi: 10.1097/IAE.0000000000001665.
10
Central Serous Chorioretinopathy Misdiagnosed as Posterior Uveitis and the Vicious Circle of Corticosteroid Therapy.中心性浆液性脉络膜视网膜病变误诊为后葡萄膜炎及糖皮质激素治疗的恶性循环
J Ophthalmic Vis Res. 2015 Jul-Sep;10(3):303-8. doi: 10.4103/2008-322X.170352.